The 20-year-old gunman who tried to assassinate President Donald Trump at a rally in Butler, Pennsylvania, last summer experienced a "descent into madness" leading up to the incident, during which he was "having conversations with someone that wasn’t there," a new report says.

The New York Times, citing thousands of pages of school assignments, internet activity logs and interviews with dozens of people who knew Thomas Matthew Crooks and the investigation surrounding him, among other documents, reported this week that "he went through a gradual and largely hidden transformation from a meek engineering student critical of political polarization to a focused killer who tried to build bombs."

Crooks’ father noticed his son’s mental health taking a turn in the year before the shooting and especially after the May 2024 graduation, telling investigators he had seen Thomas talking to himself and dancing around in his bedroom late at night, the newspaper said. The alleged behavior coincided with a history of mental health and addiction struggles in Crooks’ family, the New York Times reported, citing portions of a report from the Pennsylvania State Police.

A classmate said to the newspaper that during high school, Crooks enjoyed talking about the economy and cryptocurrencies. At community college, he reportedly designed a chess board for the visually impaired, such as his mother, the New York Times added.

About a year before graduation, in April 2023, Crooks reportedly wrote an essay in favor of ranked-choice voting in American politics, arguing against "divisive and incendiary campaigns which are pulling the country apart."

Around that same time, the FBI said, Crooks made more than 25 different firearm-related purchases from online vendors using an alias.

One purchase that Crooks made with an encrypted email address was gallons of nitromethane, a fuel additive that can be used to build explosives, according to the New York Times. He reportedly listed his home address for the delivery.
XPOST

Another thing to note. This kid didn't know what he needed. The PEOPLE or AI in his head told him what he needed.

#AktionReinhard #AktionReinhardt AR - RA ;)

" It was the single fastest rate of genocidal killing in history.[5]"

#4thReich Ra #Reinhard #Aktion

#Amun #Amen #Amon #Aamon

https://en.wikipedia.org/wiki/Operation_Reinhard

Heroes ;)

Neuroprotective properties
A unique feature of methylene blue is its ability to penetrate the blood-brain barrier and accumulate in the brain, which has led researchers to investigate the potential utility of this agent for the treatment of neurological disorders. In addition to its bioavailability in the brain, methylene blue also reduces oxidative stress in the brain. This chemical process is implicated in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. More specifically, methylene blue acts as an electron carrier in the electron transport chain, wherein it inhibits complexes I and III to promote respiration.

The neuroprotective effects of methylene blue may also be attributed to its role in increasing the expression of nuclear factor erythroid 2-related factor 2 (Nrf2). Nrf2 is a transcription factor that regulates several enzymes involved in cellular stress responses, some of which include superoxide dismutase catalase, glutathione peroxidase, and glutathione reductase5. Other mechanisms by which methylene blue may induce neuroprotective effects include facilitating the degradation and clearance of tau proteins, which is a characteristic feature of Alzheimer’s disease, promoting autophagy, and reducing amyloid plaque accumulation.

To date, several randomized clinical trials (RCTs) have investigated the potential benefits of methylene blue administration in the treatment of Alzheimer’s disease. For example, one recent study reported that patients administered leuco-methylthioninium bis-hydromethanesulfonate (LMTM), a modified version of methylene blue, exhibited enhanced cognitive performance and reduced beta-amyloid plaque buildup7. Despite these observations, additional research is needed to chemically modify methylene blue to improve its uptake into the brain and include larger and more diverse patient populations

https://www.news-medical.net/health/Potential-Health-Benefits-of-Methylene-Blue.aspx

Mine arrived from this supplier OK;

Manufactured in the UK to pharmaceutical specifications

https://www.ebay.co.uk/itm/135774461845

reminder, contra-indicated for SSRI's (and others?)

Methylene blue, which has the chemical name of 3,7

"Methylene Blue Contraindications

Methylene blue has several contraindications. It is contraindicated in patients with severe hypersensitivity reactions to methylene blue or any other thiazine dye.

Additionally, patients with glucose-6-phosphate dehydrogenase deficiency (G6PD) should not use methylene blue due to the risk of hemolytic anemia.

It is also contraindicated in patients with a history of severe hypersensitivity reactions, such as anaphylaxis, angioedema, urticaria, or bronchospasm.

Furthermore, methylene blue should not be used in combination with serotonergic psychiatric drugs (e.g., SSRIs, SNRIs, TCAs, MAOIs) due to the increased risk of serotonin syndrome, unless indicated for life-threatening conditions or when urgent treatment is required.

AI-generated answer. Please verify critical facts."

#GenocideAgenda #MiddleEast

Gordon Duff: Let us be unequivocal: what has transpired—and continues to transpire—in Gaza is a textbook case of collective punishment, ethnic cleansing, and, by several legal metrics, #genocide. This is not hyperbole. It is legal precision.

https://www.theinteldrop.org/2025/06/05/former-u-s-military-official-and-journalist-told-qodsna-legacy-of-imam-khomeini-not-just-ideological-but-architectural/